Related Experiment Video
Updated: Jun 30, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling
Huidong Wang1, Masako Nishikawa2, Yuqi Zhou1
1Department of Chemistry, The University of Tokyo, Tokyo, 113-0033, Japan.
Background:
Platelets are central to hemostasis and thrombosis and contribute to diverse diseases, including cardiovascular disorders, infections, and cancer. Although platelet activation and dysfunction in disease have been studied extensively, disease-associated platelet phenotypes remain poorly defined, largely because phenotypic changes are subtle, transient, and difficult to capture at single-cell resolution.
Methods:
We acquired bright-field images of numerous circulating platelets in whole-blood samples anticoagulated with 3.2% sodium citrate that were collected from patients (n = 65) and healthy volunteers (n = 10) at the University of Tokyo Hospital, using optofluidic imaging with an optical frequency-division-multiplexed (FDM) microscope integrated with a microfluidic chip. Convolutional neural network (CNN) models were trained to classify platelet phenotypes across disease categories. Feature-importance analysis was performed to identify image-derived parameters driving the deep-learning-based characterization.
Results:
We developed three CNN models to classify platelet images by disease category, achieving accuracies of up to 81.3%, indicating measurable associations between platelet phenotypic expression and disease type. Longitudinal analysis of platelet images further showed that the CNN models could predict thrombotic progression up to 7 days before clinical thrombus detection. Feature-importance analysis highlighted texture-related descriptors as the dominant contributors, accounting for 54.5% of overall importance.
Conclusions:
Image-based analysis of circulating platelets can capture disease-associated phenotypic signatures and may complement existing clinical workflows for prediagnosis and early assessment of thrombotic risk.

